EP1809255A4 - High-dosage extended-release formulation of gepirone - Google Patents

High-dosage extended-release formulation of gepirone

Info

Publication number
EP1809255A4
EP1809255A4 EP04800476A EP04800476A EP1809255A4 EP 1809255 A4 EP1809255 A4 EP 1809255A4 EP 04800476 A EP04800476 A EP 04800476A EP 04800476 A EP04800476 A EP 04800476A EP 1809255 A4 EP1809255 A4 EP 1809255A4
Authority
EP
European Patent Office
Prior art keywords
gepirone
release formulation
dosage extended
dosage
extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04800476A
Other languages
German (de)
French (fr)
Other versions
EP1809255A1 (en
Inventor
Stephen J Kramer
Louis F Fabre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FABRE-KRAMER HOLDINGS, INC.
Original Assignee
FABRE-KRAMER HOLDINGS Inc
FABRE KRAMER HOLDINGS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FABRE-KRAMER HOLDINGS Inc, FABRE KRAMER HOLDINGS Inc filed Critical FABRE-KRAMER HOLDINGS Inc
Publication of EP1809255A1 publication Critical patent/EP1809255A1/en
Publication of EP1809255A4 publication Critical patent/EP1809255A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP04800476A 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone Withdrawn EP1809255A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/032785 WO2006052227A1 (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Publications (2)

Publication Number Publication Date
EP1809255A1 EP1809255A1 (en) 2007-07-25
EP1809255A4 true EP1809255A4 (en) 2011-08-03

Family

ID=36336794

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04800476A Withdrawn EP1809255A4 (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Country Status (11)

Country Link
EP (1) EP1809255A4 (en)
JP (1) JP2008519071A (en)
CN (1) CN101076320A (en)
AU (1) AU2004324868B2 (en)
BR (1) BRPI0419179A (en)
CA (1) CA2585606A1 (en)
EA (1) EA013213B1 (en)
IL (1) IL182792A0 (en)
MX (1) MX2007005368A (en)
NO (1) NO20072851L (en)
WO (1) WO2006052227A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131906A1 (en) * 2013-11-18 2015-05-19 Gnosis Spa ORAL SOLID COMPOSITIONS WITH SLOW RELEASE
RU2713725C1 (en) * 2019-02-08 2020-02-06 Юрий Владимирович Соколов Biologically active additive and method of its application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045753A2 (en) * 2000-12-08 2002-06-13 Akzo Nobel N.V. Oral extended release formulation of gepirone
US20030220346A1 (en) * 2000-12-18 2003-11-27 Kramer Stephen J. Use of bioactive metabolites of gepirone for the treatment of psychological disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US6534507B1 (en) * 1999-12-20 2003-03-18 Fabre-Kramer Pharmaceuticals, Inc. Methods for treating psychological disorders using bioactive metabolites of gepirone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045753A2 (en) * 2000-12-08 2002-06-13 Akzo Nobel N.V. Oral extended release formulation of gepirone
US20030220346A1 (en) * 2000-12-18 2003-11-27 Kramer Stephen J. Use of bioactive metabolites of gepirone for the treatment of psychological disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006052227A1 *

Also Published As

Publication number Publication date
JP2008519071A (en) 2008-06-05
BRPI0419179A (en) 2007-12-18
MX2007005368A (en) 2007-09-11
NO20072851L (en) 2007-07-31
IL182792A0 (en) 2007-08-19
WO2006052227A1 (en) 2006-05-18
EA013213B1 (en) 2010-04-30
CA2585606A1 (en) 2006-05-18
EP1809255A1 (en) 2007-07-25
EA200701010A1 (en) 2007-10-26
AU2004324868B2 (en) 2010-04-29
CN101076320A (en) 2007-11-21
AU2004324868A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
HK1199874A1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
IL179991A0 (en) Modified release formulation of memantine
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
HK1213814A1 (en) Diclofenac formulations and methods of use
EP1717231A4 (en) Substituted azole compounds and thereof preparation and application
EP1841397A4 (en) Formulations and treatments for trichology
EP1720888A4 (en) Antimicrobial carbohydrates and methods of using same
SI1713999T1 (en) Cupboard-type piece of furniture
ZA200705881B (en) Formulations and treatments for well-being
EP1740541A4 (en) Therapeutic formulations of desoxyepothilones
IL181300A0 (en) Photosensitizer formulations and uses thereof
SI1812072T1 (en) Benzothiazole formulations and use thereof
HK1101869A1 (en) Leg body and furniture
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
EP1809255A4 (en) High-dosage extended-release formulation of gepirone
PL375008A1 (en) New application of epirubicine hydrochloride in medicine
ZA200703619B (en) High-dosage extended-release formulation of gepirone
GB0312844D0 (en) Use of compounds in medicine
IL185548A0 (en) Medical uses of 39-desmethoxyrapamycin and analogues thereof
GB0421767D0 (en) Compounds and their medical uses
GB0421766D0 (en) Compounds and their medical uses
TW579764U (en) Improved structure of leg of table
GB0412882D0 (en) New formulation of eletriptan
IL160203A0 (en) Structure of furniture
TW543409U (en) Structure of leg for furniture

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070426

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK YU

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: FABRE-KRAMER HOLDINGS, INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1107676

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20110704

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/506 20060101ALI20110628BHEP

Ipc: A61K 9/48 20060101ALI20110628BHEP

Ipc: A61K 9/20 20060101AFI20110628BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111001

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1107676

Country of ref document: HK